Advertisement

Does Tumor Bank Regulation Promote the Valorization of Tumor Collections?

  • Anna Pigeon
Chapter

Abstract

Biobanks regulation has gradually developed following scientific and normative needs, which has led to the coexistence of a heterogeneous set of rules. Several regulations are applicable depending on the context of how the following were collected: elements of the human body and associated personal data, their conditions of conservation, and the purpose of their use. Thus, tumor banks must combine the provisions of bioethics law, public health laws with those of the data protection Act, and with that of research involving human individuals. The accumulation of rules can mean hindrance and difficulties for those concerned. The availability of biological samples to researchers, and so their scientific development, can thus be hampered by a too complex legislation which is difficult to access for its recipients. Therefore, the question that arises is the following: do biobank regulations, consisting of scattered legal rules, constitute a brake on the valorization of these activities, and do they promote the development of the biological sample collections?

References

  1. Bellivier, F., & Noiville, C. (2009). Les biobanques (128 p). PUF, coll. Que sais-je?.Google Scholar
  2. Bioy, X. (2010). Vers une politique publique des biobanques. Revue de droit sanitaire et social, 885.Google Scholar
  3. Chemtob-Concé, M.-C., & Cailleux, A. (2013). L’impact des nouvelles dispositions de la loi relative aux recherches impliquant la personne humaine. Médecine et Droit, 30–35.Google Scholar
  4. Cornu, G. (2016). Vocabulaire juridique (11th ed.). Paris: Puf. coll. Quadrige.Google Scholar
  5. Coulibaly, I. (2011). La protection des données à caractère personnel dans la recherche scientifique. PhD, Université de Grenoble, 1117 p., p. 156.Google Scholar
  6. Dionisi-Peyrusse, A. (2012). The law of March 5th, 2012 on research involving the human person: looking for a balance between protection of the person and development of research for medical progress. Revue juridique personne et famille.Google Scholar
  7. Galloux, J. C., & Gaumont-Prat, H. (2017). Droits et libertés corporelles, February 2016–February 2017. Recueil Dalloz.Google Scholar
  8. Rial-Sebbag, E. (2009). Implication juridiques des nouvelles formes de gouvernance en biotechnologies : l’exemple des biobanques utilisées en recherche. PhD, Université Toulouse Paul Sabatier.Google Scholar
  9. Rial-Sebbag, E. (2008). Genèse d’un cadre réglementaire pour les collections d’échantillons biologiques utilisées en recherche. Exploration d’un modèle de gouvernance. RGDM, 27, 233–271.Google Scholar
  10. Thouvenin, D. (2012). La loi n°2012-300 du 05 mars 2012; des recherches pratiquées sur la personne aux recherches avec la personne. RDSS, 787.Google Scholar
  11. Thouvenin, D. (2005a). Les banques de tissus et d’organes : les mots pour le dire, les règles pour les organiser. LPA, (35) 31.Google Scholar
  12. Thouvenin, D. (2005b). La loi relative à la bioéthique ou comment accroître l’accès aux éléments biologiques d’origine humaine. Recueil Dalloz, (2), 116–121.Google Scholar
  13. Washetine, K., Ilié, M., Hofman, V., Butori, C., Long, E., Lassalle, S., et al. (2017, 2017). Les biobanques, quels enjeux en 2017. Revue francophone des laboratoires, (488), 25–27.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Anna Pigeon
    • 1
    • 2
  1. 1.University Toulouse 1 Capitole, Maurice Hauriou InstituteToulouseFrance
  2. 2.Tumor Banks ProjectToulouseFrance

Personalised recommendations